PubRank

J Lubinski

Author PubWeight™ 83.09‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003 18.67
2 The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer 2008 3.87
3 Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients. Breast Cancer Res Treat 2008 2.27
4 Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies. J Med Genet 2005 1.91
5 In vitro synthesis of infectious poliovirus RNA. Proc Natl Acad Sci U S A 1985 1.78
6 Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study. BJU Int 2010 1.60
7 In vivo immune evasion mediated by the herpes simplex virus type 1 immunoglobulin G Fc receptor. J Virol 1998 1.59
8 Non-random transmission of mutant alleles to female offspring of BRCA1 carriers in Poland. J Med Genet 2003 1.57
9 Response to neo-adjuvant chemotherapy in women with BRCA1-positive breast cancers. Breast Cancer Res Treat 2007 1.44
10 Novel mutations in the LKB1/STK11 gene in Dutch Peutz-Jeghers families. Hum Mutat 1999 1.39
11 Recommendations to improve identification of hereditary and familial colorectal cancer in Europe. Fam Cancer 2009 1.38
12 Immune evasion properties of herpes simplex virus type 1 glycoprotein gC. J Virol 1996 1.36
13 Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients. Breast Cancer Res Treat 2014 1.35
14 Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 2004 1.34
15 The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers. Br J Cancer 2012 1.34
16 Value of pedigree/clinical data, immunohistochemistry and microsatellite instability analyses in reducing the cost of determining hMLH1 and hMSH2 gene mutations in patients with colorectal cancer. Eur J Cancer 2000 1.31
17 Suspected hereditary nonpolyposis colorectal cancer: International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) criteria and results of genetic diagnosis. Dis Colon Rectum 1999 1.29
18 A common variant of CDKN2A (p16) predisposes to breast cancer. J Med Genet 2005 1.22
19 Herpes simplex virus type 1 glycoprotein E domains involved in virus spread and disease. J Virol 2000 1.19
20 Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events. Cancer Res 1997 1.18
21 Absence or reduction of Fhit expression in most clear cell renal carcinomas. Cancer Res 1998 1.18
22 The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)--results of an international collaborative study. Fam Cancer 2001 1.13
23 Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study. Br J Cancer 2012 1.12
24 Common variants of DNA repair genes and malignant melanoma. Eur J Cancer 2007 1.02
25 Novel mechanism of antibody-independent complement neutralization of herpes simplex virus type 1. J Immunol 2000 1.00
26 Vitamin D receptor variants and the malignant melanoma risk: a population-based study. Cancer Epidemiol 2009 0.97
27 FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium. Br J Cancer 2014 0.96
28 Founder mutations in the BRCA1 gene in west Belarusian breast-ovarian cancer families. Clin Genet 2001 0.94
29 Purification of a soluble template-dependent rhinovirus RNA polymerase and its dependence on a host cell protein for viral RNA synthesis. J Virol 1985 0.93
30 CHEK2 variants predispose to benign, borderline and low-grade invasive ovarian tumors. Gynecol Oncol 2006 0.92
31 Cancer risks in first degree relatives of BRCA1 mutation carriers: effects of mutation and proband disease status. J Med Genet 2005 0.92
32 A protein truncating BRCA1 allele with a low penetrance of breast cancer. J Med Genet 2004 0.89
33 Characterization of a familial RCC-associated t(2;3)(q33;q21) chromosome translocation. J Hum Genet 2001 0.89
34 Effect of CHEK2 missense variant I157T on the risk of breast cancer in carriers of other CHEK2 or BRCA1 mutations. J Med Genet 2008 0.88
35 Vitamin D receptor variants and breast cancer risk in the Polish population. Breast Cancer Res Treat 2008 0.87
36 Xeroderma pigmentosum genes and melanoma risk. Int J Cancer 2013 0.86
37 Short report. The AIDIT and IMPACT conference 2006: Outcomes and future directions. Hered Cancer Clin Pract 2007 0.85
38 Founder mutations of BRCA1 and BRCA2 in North American families of Polish origin that are affected with breast cancer. Am J Hum Genet 2001 0.84
39 Optimization of experimental conditions for RNA-based sequencing of MLH1 and MSH2 genes. Hum Mutat 2001 0.83
40 Intermediate filament typing of tumor cells in fine needle aspirates by means of monoclonal antibodies. Acta Cytol 1986 0.83
41 XPD common variants and their association with melanoma and breast cancer risk. Breast Cancer Res Treat 2006 0.83
42 Comparison of Alu-PCR, microsatelite instability, and immunohistochemical analyses in finding features characteristic for hereditary nonpolyposis colorectal cancer. J Cancer Res Clin Oncol 2001 0.81
43 The -149C>T SNP within the DeltaDNMT3B gene, is not associated with early disease onset in hereditary non-polyposis colorectal cancer. Cancer Lett 2008 0.81
44 Loss or reduction of Fhit expression in renal neoplasias: correlation with histogenic class. Hum Pathol 1999 0.81
45 Losses at 3p common deletion sites in subtypes of kidney tumours: histopathological correlations. Virchows Arch 1996 0.81
46 Transmission of mutant alleles to female offspring of BRCA1 carriers in Poland. J Med Genet 2005 0.80
47 Neuroendocrine (Merkel-cell) carcinoma of the skin. Cytology, intermediate filament typing and ultrastructure of tumor cells in fine needle aspirates. Acta Cytol 1987 0.80
48 Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband. Br J Cancer 2009 0.80
49 Studies on the pharmacokinetics and metabolism of a gamma-secretase inhibitor BMS-299897, and exploratory investigation of CYP enzyme induction. Xenobiotica 2009 0.80
50 An evaluation of the polymorphisms Ins16bp and Arg72Pro in p53 as breast cancer risk modifiers in BRCA1 and BRCA2 mutation carriers. Br J Cancer 2008 0.79
51 Parental origin of mutation and the risk of breast cancer in a prospective study of women with a BRCA1 or BRCA2 mutation. Clin Genet 2012 0.79
52 Common variants of ZNF750, RPTOR and TRAF3IP2 genes and psoriasis risk. Arch Dermatol Res 2013 0.78
53 Novel RB1 gene constitutional mutations found in Polish patients with familial and/or bilateral retinoblastoma. Hum Mutat 2001 0.78
54 Characterization of the c.190T>C missense mutation in BRCA1 codon 64 (Cys64Arg). Int J Oncol 2009 0.78
55 Detection of germline mutations in the BRCA1 gene by RNA-based sequencing. Hum Mutat 2001 0.78
56 Patterns of anti-phospholipid antibody specificities. J Clin Lab Immunol 1991 0.77
57 Detection of specific genetic alterations in cancer cells. Semin Oncol 1996 0.77
58 Molecular evidence for derivation of metastatic cells from minor subclones of primary clear renal cell carcinomas. Cancer Detect Prev 1999 0.77
59 AIDIT and IMPACT: building research collaborations in targeted prostate cancer screening. J BUON 2007 0.77
60 The DIRC1 gene at chromosome 2q33 spans a familial RCC-associated t(2;3)(q33;q21) chromosome translocation. J Hum Genet 2001 0.76
61 Decisive role of intermediate filament typing of tumor cells in the differential diagnosis of difficult fine needle aspirates. Acta Cytol 1987 0.76
62 Are two-centimeter breast cancers large or small? Curr Oncol 2013 0.75
63 Gene rearrangements detected by nonradioactive digoxigenin-labeled DNA probes. Anal Quant Cytol Histol 1991 0.75
64 Survival in patients with rare subtypes of renal cell carcinoma. BJU Int 2002 0.75
65 Independent variation in the number of coated pits and of coated vesicles in cultured fibroblasts. Biol Cell 1984 0.75
66 Clinical genetic services for familial breast cancer in Poland. Dis Markers 1999 0.75
67 Cellular, biochemical, and molecular basis of T-cell senescence. Arch Pathol Lab Med 1987 0.75
68 A survey of preventive measures among BRCA1 mutation carriers from Poland. Clin Genet 2007 0.75
69 Diagnosis of metastatic renal cell and thyroid carcinomas by intermediate filament typing and cytology of tumor cells in fine needle aspirates. Acta Cytol 1988 0.75